Small Molecules Efficiently Reprogram Human Astroglial Cells into Functional Neurons
Overview
Authors
Affiliations
We have recently demonstrated that reactive glial cells can be directly reprogrammed into functional neurons by a single neural transcription factor, NeuroD1. Here we report that a combination of small molecules can also reprogram human astrocytes in culture into fully functional neurons. We demonstrate that sequential exposure of human astrocytes to a cocktail of nine small molecules that inhibit glial but activate neuronal signaling pathways can successfully reprogram astrocytes into neurons in 8-10 days. This chemical reprogramming is mediated through epigenetic regulation and involves transcriptional activation of NEUROD1 and NEUROGENIN2. The human astrocyte-converted neurons can survive for >5 months in culture and form functional synaptic networks with synchronous burst activities. The chemically reprogrammed human neurons can also survive for >1 month in the mouse brain in vivo and integrate into local circuits. Our study opens a new avenue using chemical compounds to reprogram reactive glial cells into functional neurons.
Gresita A, Hermann D, Boboc I, Doeppner T, Petcu E, Semida G Transl Stroke Res. 2025; .
PMID: 39904845 DOI: 10.1007/s12975-025-01331-7.
Cates K, Yuan L, Yang Y, Yoo A Cell Rep. 2025; 44(1):115153.
PMID: 39756035 PMC: 11834941. DOI: 10.1016/j.celrep.2024.115153.
Using Small Molecules to Reprogram RPE Cells in Regenerative Medicine for Degenerative Eye Disease.
Rzhanova L, Alpeeva E, Aleksandrova M Cells. 2024; 13(23).
PMID: 39682681 PMC: 11640686. DOI: 10.3390/cells13231931.
Conversion of glioma cells into neuron-like cells by small molecules.
Yi Y, Che W, Xu P, Mao C, Li Z, Wang Q iScience. 2024; 27(11):111091.
PMID: 39483145 PMC: 11525470. DOI: 10.1016/j.isci.2024.111091.
3D model for human glia conversion into subtype-specific neurons, including dopamine neurons.
Giacomoni J, Bruzelius A, Habekost M, Kajtez J, Ottosson D, Fiorenzano A Cell Rep Methods. 2024; 4(9):100845.
PMID: 39236715 PMC: 11440053. DOI: 10.1016/j.crmeth.2024.100845.